» Articles » PMID: 18035154

Multicenter Prospective Study of Ulcerated Hemangiomas

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2007 Nov 24
PMID 18035154
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify clinical features of infants with ulcerated infantile hemangiomas.

Study Design: Cross-sectional analysis was conducted within a prospective cohort study of children with infantile hemangiomas. Children younger than 12 years of age were recruited. Demographic and prenatal/perinatal information was collected. Hemangioma size, location, subtype, course, complications, and treatments were recorded.

Results: One thousand ninety-six patients were enrolled, and 173 (15.8%) patients experienced ulceration. Ulceration occurred in 192 (9.8%) of 1960 [corrected] total hemangiomas. Hemangiomas with ulcerations were more likely large, mixed clinical type, segmental morphologic type, and located on the lower lip, neck, or anogenital region. Ulceration occurred at a median age of 4 months, most often during the proliferative phase. Children with ulcerated hemangiomas were more likely to present to a pediatric dermatologist at a younger age and to require treatment. Bleeding occurred in 41% of ulcerated lesions but was rarely of clinical significance. Infection occurred in 16%.

Conclusions: Ulceration occurs in nearly 16% of patients with infantile hemangiomas, most often by 4 months of age, during the proliferative phase. Location, size, and clinical and morphologic type are associated with an increased risk for development of ulceration.

Citing Articles

The Evaluation, Diagnosis, and Management of Infantile Hemangiomas-A Comprehensive Review.

Resic A, Barcot Z, Habek D, Pogorelic Z, Baskovic M J Clin Med. 2025; 14(2).

PMID: 39860430 PMC: 11765582. DOI: 10.3390/jcm14020425.


Efficacy and safety of propranolol tablets vs. oral solution in neonates with severe infantile hemangiomas: a retrospective study in China.

Wu Z, Zou Y, Yuan H, Fu R, Jin P Sci Rep. 2025; 15(1):459.

PMID: 39747987 PMC: 11696479. DOI: 10.1038/s41598-024-84653-0.


Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review.

Bellinato F, Marocchi M, Pecoraro L, Zaffanello M, Del Giglio M, Girolomoni G Children (Basel). 2024; 11(11).

PMID: 39594972 PMC: 11593309. DOI: 10.3390/children11111397.


Efficiency of Topical Beta-Blockers for Epistaxis Control in Ulcerated Infantile Hemangioma.

Lam N, Schrepfer T Cureus. 2024; 16(8):e67709.

PMID: 39318943 PMC: 11420686. DOI: 10.7759/cureus.67709.


Infantile hemangiomas: a dermatologist's perspective.

Sharma A, Gupta M, Mahajan R Eur J Pediatr. 2024; 183(10):4159-4168.

PMID: 39052139 DOI: 10.1007/s00431-024-05655-8.